If you haven't heard this news yet, it's worth a moment: the FDA recently approved Ocrevus for children ages 10+ with relapsing-remitting MS—only the second FDA-approved therapy for pediatric MS in the U.S. The approval was based on clinical trial results showing reduced relapses and new or enlarging lesions, offering new hope for young people and families navigating life with MS. Fewer relapses can mean more time in school, more independence, and fewer disruptions to the everyday moments that matter most growing up. The next breakthrough starts with the people living it. iConquerMS Kids & Teens, a program of Accelerated Cure Project for MS, is where young people and families can be part of the research driving what comes next. If you're a parent, caregiver, or young person living with MS, we'd love for you to join us. Learn more here: https://lnkd.in/ga2jSPsp Read the full article here: https://lnkd.in/gUeS3NXG #MultipleSclerosis #MSResearch #PediatricMS
